Spyros Papapetropoulos

CIK 1832694 · President and CEO · last filed 2025-09-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$49.1K

Companies

4

Total Filings

16

Lifetime Open-Market Net

$49.8K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NEUP President and CEO $4.37 $0 3 2025-09-02
LPCN Director 21,739 $2.26 $49.1K $10.2K 6 2025-06-05
Vigil Neuroscience, Inc. (VIGL) Delisted Chief Medical Officer 4,000 $8.05 $32.2K $9.4K 3 2022-11-22
Adamas Pharmaceuticals Inc (ADMS) Delisted Director 0 $8.22 $0 $30.2K 4 2021-11-24

Recent Filings · Page 2 of 2

16 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-04-12 LPCN Grant (A) $0 EDGAR
2022-03-03 Vigil Neuroscience, Inc. (VIGL) Delisted Grant (A) $0 EDGAR
2021-11-24 Adamas Pharmaceuticals Inc (ADMS) Delisted Mixed −20,975 $0 EDGAR
2021-06-04 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) +5,000 $0 EDGAR
2021-03-15 Adamas Pharmaceuticals Inc (ADMS) Delisted Buy (P) +5,975 $30.2K EDGAR
2020-11-24 Adamas Pharmaceuticals Inc (ADMS) Delisted Grant (A) +10,000 $0 EDGAR
Showing 1116 of 16
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.